A method and article to treat ocular disease with Cyclosporin A alone or with compounds related to Cyclosporin A for intraocular injection or implantation. Treatment does not result in ocular toxicity and encompasses age related macular degeneration, retinitis pigmentosa, and retinopathy such as diabetic retinopathy.

 
Web www.patentalert.com

< Self-assembly of peptide-amphiphile nanofibers under physiological conditions

> Genetically modified tumor-targeted bacteria with reduced virulence

~ 00425